News Focus
News Focus
icon url

DewDiligence

03/19/15 9:04 AM

#188789 RE: iwfal #188787

JNJ acquires (private) XO1 Ltd to develop anticoagulant, Ichorcumab:

http://finance.yahoo.com/news/janssen-acquires-xo1-limited-080000722.html

Financial terms have not been disclosed.
icon url

iwfal

07/21/17 8:02 AM

#212536 RE: iwfal #188787

Ichorcumab, an anticoagulant with potentially substantially lower bleeding risk, resurfaces as JNJ-375 2 years after Jansen bought out original company. (It hasn't been in their pipeline charts...)

http://isthcongressdaily.org/improving-therapeutic-index-jnj-375-novel-long-acting-exosite-1-thrombin-inhibitor-animal-models/

H/t @mikeNGladstone